Odevixibat is an Orally Active ASBT Inhibitor for Primary Sclerosing Cholangitis Research
Primary sclerosing cholangitis (PSC) is a rare chronic cholestatic liver disease. In addition, the characteristics of PSC are inflammatory destruction of the intrahepatic and/or extrahepatic bile ducts, leading to bile…